Skip to main content

Peer Review reports

From: IMI2-PainCare-BioPain-RCT3: a randomized, double-blind, placebo-controlled, crossover, multi-center trial in healthy subjects to investigate the effects of lacosamide, pregabalin, and tapentadol on biomarkers of pain processing observed by electroencephalography (EEG)

Original Submission
20 Oct 2020 Submitted Original manuscript
3 Mar 2021 Reviewed Reviewer Report - Kirsty Loudon
8 Apr 2021 Author responded Author comments - André Mouraux
Resubmission - Version 2
8 Apr 2021 Submitted Manuscript version 2
15 Apr 2021 Editorially accepted
17 Jun 2021 Article published 10.1186/s13063-021-05272-y

You can find further information about peer review here.

Back to article page